More: ERYTECH Provides Business and Financial Update for the First Quarter of 2023
More: ERYTECH Provides Business and Financial Update for the First Quarter of 2023
Read more here: Bio-Path Holdings to Announce First Quarter 2023 Financial Results on May 12, 2023
See the rest here: Editas Medicine Announces First Quarter 2023 Results and Business Updates
Continued here: CENTOGENE to Participate in Upcoming Conferences in May
See the article here: Arvinas Reports First Quarter 2023 Financial Results and Provides Corporate Update
Read the original here: Aerami Therapeutics Mourns the Sudden Loss of Chief Executive Officer Lisa Yañez
Read this article: Ovid Therapeutics Reports First Quarter 2023 Financial Results and Corporate Updates
See the original post here: Ocugen Provides Business Update with First Quarter 2023 Financial Results
Read more here: FibroGen Announces Results for MATTERHORN, a Phase 3 Clinical Study of Roxadustat for the Treatment of Anemia in Patients with Myelodysplastic...
Excerpt from: InspireMD Announces May 15th as New Date for First Quarter 2023 Financial Results and Corporate Business Update
Recent Comments